# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

> **NCT00004093** · PHASE1,PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 36 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** Gemcitabine
- **DRUG:** paclitaxel
- **DRUG:** vinorelbine
- **RADIATION:** radiation therapy
- **DRUG:** Navelbine
- **DRUG:** Taxol

## Key facts

- **NCT ID:** NCT00004093
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-08
- **Primary completion:** 2002-02
- **Final completion:** 2002-03
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Original Principal Investigator left the institution.
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004093, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00004093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*